Abstract
Macrophages (mϕ) from pre-diseased mice of the major murine inbred models of spontaneous autoimmunity (AI), including multiple lupus-prone strains and the type I diabetes-prone NOD (non-obese diabetic) strain, have identical apoptotic target-dependent abnormalities. This characteristic feature of mϕ from AI-prone mice suggests that abnormal signaling events induced within mϕ following their interaction with apoptotic targets may predispose to AI. Such signaling abnormalities would affect predominantly the processing and presentation of self-antigen (i.e., derived from apoptotic targets), while sparing the processing and presentation of foreign antigen (i.e., derived from non-apoptotic sources). Here, we used DNA microarrays to test the hypothesis that mϕ from AI-prone mice (MRL/MpJ [MRL/+] or MRL/MpJ-Tnfrsf6 lpr [MRL/lpr]) differentially express multiple genes in comparison to non-AI mϕ (BALB/c), but do so in a largely apoptotic cell-dependent manner. Mϕ were stimulated with lipopolysaccharide, a potent innate stimulus, in the presence or absence of serum (an experimental surrogate for apoptotic targets). In accord with our hypothesis, the number of genes differentially expressed by MRL mϕ was significantly increased in the presence vs. the absence of serum, the apoptotic target surrogate (n = 401 vs. n = 201). Notably, for genes differentially expressed by MRL mϕ in the presence of serum, serum-free culture normalized their expression to a level statistically indistinguishable from that by non-AI mϕ. Comparisons of mϕ from AI-prone NOD and non-AI C57BL/6 mice corroborated these findings. Together, these data support the hypothesis that mϕ from MRL and other AI-prone mice are characterized by a conditional abnormality elicited by serum lipids or apoptotic targets.
Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Similar content being viewed by others
References
Botto M, Dell’Agnola C, Bygrave AE, Thompson EM, Cook HT, Petry F, Loos M, Pandolfi PP, Walport MJ (1998) C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 19:56–59
Casciola-Rosen LA, Anhalt G, Rosen A (1994) Autoantigens targeted in SLE are clustered in two population of surface structures on apoptotic keratinocytes. J Exp Med 179:1317–1330
Chang MK, Bergmark C, Laurila A, Hörkkö S, Han KH, Friedman P, Dennis EA, Witztum JL (1999) Monoclonal antibodies against oxidized LDL bind to apoptotic cells and inhibit their phagocytosis by elicited macrophages. Proc Natl Acad Sci U S A 96:6353–6358
Chen M, Wang Y-H, Wang Y, Huang L, Sandoval H, Liu Y-J, Wang J (2006) Dendritic cell apoptosis in the maintenance of immune tolerance. Science 311:1160–1164
Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R, Selleri L, Ma X (2007) Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity 27:952–964
Cline AM, Radic MZ (2004) Murine autoantibodies identify distinct sets of apoptotic bodies. Autoimmunity 37:85–93
Cocco RE, Ucker DS (2001) Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell 12:919–930
Cohen PL, Caricchio R, Abraham V, Camenisch TD, Jennette JC, Roubey RA, Earp HS, Matsushima G, Reap EA (2002) Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J Exp Med 196:135–140
Concannon P, Erlich HA, Julier C, Morahan G, Nerup J, Pociot F, Todd JA, Rich SS (2005) Evidence for susceptibility loci from four genome-wide linkage scans in 1, 435 multiplex families. Diabetes 54:2995–3001
Cvetanovic M, Ucker DS (2004) Innate immune discrimination of apoptotic cells: repression of proinflammatory macrophage transcription is coupled directly to specific recognition. J Immunol 172:880–889
Cvetanovic M, Mitchell JE, Patel V, Avner BS, Su Y, van der Saag PT, Witte PL, Fiore S, Levine JS, Ucker DS (2006) Specific recognition of apoptotic cells reveals a ubiquitous and unconventional innate immunity. J Biol Chem 281:20055–20067
de Almeida CJG, Linden R (2005) Phagocytosis of apoptotic cells: matter of balance. Cell Mol Life Sci 62:1532–1546
Donnelly RP, Levine J, Hartwell DW, Frendl G, Fenton MJ, Beller DI (1990) Aberrant regulation of interleukin 1 expression in macrophages from young autoimmune-prone mice. J Immunol 145:3231–3239
Edwards CJ, Cooper C (2006) Early environmental exposure and development of lupus. Lupus 15:814–819
Erwig L-P, Henson PM (2008) Clearance of apoptotic cells by phagocytes. Cell Death Differ 15:243–250
Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-β, PGE2, and PAF. J Clin Invest 101:890–898
Fairhurst AM, Wandstrat AE, Wakeland EK (2006) Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 92:1–69
Fan H, Longacre A, Meng F, Patel V, Hsiao K, Koh JS, Levine JS (2004) Cytokine dysregulation induced by apoptotic cells is a shared characteristic of macrophages from NOD and SLE-prone mice. J Immunol 172:4834–4843
Fan H, Patel VA, Longacre A, Levine JS (2006) Abnormal regulation of the cytoskeletal regulator Rho typifies macrophages of the major murine models of spontaneous autoimmunity. J Leukoc Biol 79:155–165
Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Arai H, Inoue K (1996) SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 222:246–250
Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M (2005) Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev 4:189–194
Harley JB, Alarcón-Riquelme ME, Criswell LA, Jacob CO, Kimberly RP, Moser KL, Tsao BP, Vyse TJ, Langefeld CD, for The International Consortium for Systemic Lupus Erythematosus Genetics (SLEGEN) (2008) Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci. Nat Genet 40:204–210
Koh JS, Wang Z, Levine JS (2000) Cytokine dysregulation induced by apoptotic cells is a shared characteristic of murine lupus. J Immunol 165:4190–4201
Krysko DV, D’Herde K, Vandenabeele P (2006) Clearance of apoptotic and necrotic cells and its immunological consequences. Apoptosis 11:1709–1726
Levine JS, Pugh BJ, Hartwell D, Fitzpatrick JM, Marshak-Rothstein A, Beller DI (1993) IL-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur J Immunol 23:2951–2958
Levine JS, Subang R, Nasr SH, Fournier S, Rauch J (2006) Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of SLE. J Immunol 177:6504–6516
Liu K, Li QZ, Yu Y, Liang C, Subramanian S, Zeng Z, Wang HW, Xie C, Zhou XJ, Mohan C, Wakeland EK (2007) Sle3 and Sle5 can independently couple with Sle1 to mediate severe lupus nephritis. Genes Immun 8:634–645
Longacre A, Koh JS, Hsiao K-H, Gilligan H, Fan H, Patel VA, Levine JS (2004) Macrophages from lupus-prone MRL mice are characterized by abnormalities in Rho activity, cytoskeletal organization, and adhesiveness to extracellular matrix proteins. J Leukoc Biol 76:971–984
Longacre A, Scott LR, Levine JS (2005) Linear independence of pair-wise comparisons of DNA microarray data. J Bioinform Comput Biol 3:1243–1262
Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM (1998) Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 188:1493–1501
Mitchell JE, Cvetanovic M, Tibrewal N, Patel V, Colamonici OR, Li MO, Flavell RA, Levine JS, Birge RB, Ucker DS (2006) The presumptive phosphatidylserine receptor is dispensable for innate antiinflammatory recognition and clearance of apoptotic cells. J Biol Chem 281:5718–5725
Nath SK, Han S, Kim-Howard X, Kelly JA, Viswanathan P, Gilkeson GS, Chen W, Zhu C, McEver RP, Kimberly RP, Alarcon-Riquelme ME, Vyse TJ, Li Q-Z, Wakeland EK, Merrill JR, James JA, Kaufman KM, Guthridge JM, Harley JB (2008) A nonsynonymous functional variant in integrinalpha(M) is associated with SLE. Nat Genet 40:131–133
Patel VA, Longacre A, Hsiao K, Fan H, Meng F, Mitchell JE, Rauch J, Ucker DS, Levine JS (2006) Apoptotic cells, at all stages of the death process, trigger characteristic signaling events that are divergent from and dominant over those triggered by necrotic cells: implications for the delayed clearance model of autoimmunity. J Biol Chem 281:4663–4670
Patel VA, Longacre-Antoni A, Cvetanovic M, Lee DJ, Feng L, Fan H, Rauch J, Ucker DS, Levine JS (2007) The affirmative response of the innate immune system to apoptotic cells. Autoimmunity 40:274–280
Reddy SM, Hsiao KH, Abernethy VE, Fan H, Longacre A, Lieberthal W, Rauch J, Koh JS, Levine JS (2002) Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J Immunol 169:702–713
Ribaudo R, Gilman M, Kingston RE, Chomczynski P, Sacchi N (2002) Preparation and analysis of RNA. In: Coligan JE, Kruisbeek AM, Marguilies DH, Shevach EM, Strober W (eds) Current protocols in immunology. Wiley, New York, pp 10.11.1–10.11.14
Richardson NI, MM KSN, Nicolo D, Monestier M, Radic MZ (2007) Divergent members of a single autoreactive B cell clone retain specificity for apoptotic blebs. Mol Immunol 44:1914–1921
Sarzi-Puttini P, Atzeni F, Iaccarino L, Doria A (2005) Environment and SLE. Autoimmunity 38:465–472
Stohl W, Jacob N, Quinn WJ III, Cancro MP, Gao H, Putterman C, Gao X, Pricop L, Koss MN (2008) Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFFindependent, SLE-like autoimmunity. J Immunol 181:833–841
Takeuchi T, Tsuzaka K, Abe T, Yoshimoto K, Shiraishi K, Kameda H, Amano K (2005) T cell abnormalities in systemic lupus erythematosus. Autoimmunity 38:339–346
Tsubata T (2004) B cell abnormality and autoimmune disorders. Autoimmunity 38:331–337
Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390:350–351
Zhu J, Liu X, Xie C, Yan M, Yu Y, Sobel ES, Wakeland EK, Mohan C (2005) T cell hyperactivity in lupus as a consequence of hyperstimulatory antigen-presenting cells. J Clin Invest 115:1869–1878
Acknowledgments
This work was supported by: National Institutes of Health grants DK59793 (to JSL) and HL69722 (to JSL); National Institutes of Health training grant T32DK07510 (to AA); Canadian Institute of Health Research grants MOP-42391 (to JR) and MOP-67101 (to JR); and a Genzyme Renal Innovation Program award from Genzyme, Inc (to JSL). The authors thank the University of Chicago Functional Genomics Facility, headed by Richard Quigg, and especially Xinmin Li, Jaejung Kim, Jamie Zhou, Chris Dyanov, and Miglena Petkova, for cRNA labeling and hybridization.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 486 kb)
Rights and permissions
About this article
Cite this article
Antoni, A., Patel, V.A., Fan, H. et al. Macrophages from lupus-prone MRL mice have a conditional signaling abnormality that leads to dysregulated expression of numerous genes. Immunogenetics 63, 291–308 (2011). https://doi.org/10.1007/s00251-010-0507-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00251-010-0507-3